Aim: To evaluate the diagnostic performance of computer-aided detection (CAD)-enhanced synthetic mammograms in comparison with standard synthetic mammograms and full-field digital mammography (FFDM).
Materials And Methods: A CAD-enhanced synthetic mammogram, a standard synthetic mammogram, and FFDM were available in 68 breast-screening cases recalled for soft-tissue abnormalities (masses, parenchymal deformities, and asymmetric densities). Two radiologists, blinded to image type and final assessment outcome, retrospectively read oblique and craniocaudal projections for each type of mammogram. The resulting 204 pairs of 2D images were presented in random order and scored on a five-point scale (1, normal to 5, malignant) without access to the Digital breast tomosynthesis (DBT) slices. Receiver operating characteristic (ROC) curve analysis was performed.
Results: There were 34 biopsy-proven malignancies and 34 normal/benign cases. Diagnostic accuracy was significantly improved for the CAD-enhanced synthetic mammogram compared to the standard synthetic mammogram (area under the ROC curve [AUC]=0.846 and AUC=0.683 respectively, p=0.004) and compared to the conventional 2D FFDM (AUC=0.724, p=0.027). The CAD-enhanced synthetic mammogram had the highest diagnostic accuracy for all soft-tissue abnormalities, and for malignant lesions sensitivity was not affected by tumour size. For all 68 cases, there was an average of 3.2 areas enhanced per image. For the 34 cancer cases, 97.4% of lesions were correctly enhanced, with 2.1 false areas enhanced per image.
Conclusions: CAD enhancement significantly improves performance of synthetic 2D mammograms and also exhibits improved diagnostic accuracy compared to conventional 2D FFDM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.crad.2018.05.028 | DOI Listing |
Bioengineering (Basel)
January 2025
School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Breast cancer ranks as the second most prevalent cancer globally and is the most frequently diagnosed cancer among women; therefore, early, automated, and precise detection is essential. Most AI-based techniques for breast cancer detection are complex and have high computational costs. Hence, to overcome this challenge, we have presented the innovative LightweightUNet hybrid deep learning (DL) classifier for the accurate classification of breast cancer.
View Article and Find Full Text PDFPhys Med
January 2025
Medical Physics Unit, ASST Monza, Monza, Italy.
Purpose: Digital Breast Tomosynthesis (DBT) is an advanced mammography technique for which there are currently no internationally agreed methods and reference values for image quality assessment. The aim of this multicentre study was to evaluate a simple method to assess the technical image quality of reconstructed and synthetic 2D (SM) images of different models of DBT systems using commercially available phantoms.
Methods: The signal difference to noise ratio (SDNR) was chosen as an index of technical image quality and was evaluated for three commercial phantoms, Tomophan, Tormam and CIRS model 015, on 55 DBT systems (six vendors, nine models).
J Med Imaging (Bellingham)
January 2025
Lund University, Department of Translational Medicine, Medical Radiation Physics, Malmö, Sweden.
Purpose: We aim to investigate the characteristics and evaluate the performance of synthetic mammograms (SMs) based on wide-angle digital breast tomosynthesis (DBT) compared with digital mammography (DM).
Approach: Fifty cases with both synthetic and digital mammograms were selected from the Malmö Breast Tomosynthesis Screening Trial. They were categorized into five groups consisting of normal cases and recalled cases with false-positive and true-positive findings from DM and DBT only.
Eur J Radiol
January 2025
Department of Radiology, Affiliated Hospital of Jiangnan University, Wuxi City, Jiangsu Province 214062, China. Electronic address:
Purpose: To construct a nomogram combining Kaiser score (KS), synthetic MRI (syMRI) parameters, apparent diffusion coefficient (ADC), and clinical features to distinguish benign and malignant breast lesions better.
Methods: From December 2022 to February 2024, a retrospective cohort of 168 patients with breast lesions diagnosed as Breast Imaging Reporting and Data System (BI-RADS) category 4 by ultrasound and/or mammography was included. The research population was divided into the training set (n = 117) and the validation set (n = 51) by random sampling with a ratio of 7:3.
Breast Cancer Res Treat
January 2025
Massachusetts General Hospital, 55 Fruit St, WAC 240, Boston, MA, 02114, USA.
Purpose: Traditional computer-assisted detection (CADe) algorithms were developed for 2D mammography, while modern artificial intelligence (AI) algorithms can be applied to 2D mammography and/or digital breast tomosynthesis (DBT). The objective is to compare the performance of a traditional machine learning CADe algorithm for synthetic 2D mammography to a deep learning-based AI algorithm for DBT on the same mammograms.
Methods: Mammographic examinations from 764 patients (mean age 58 years ± 11) with 106 biopsy-proven cancers and 658 cancer-negative cases were analyzed by a CADe algorithm (ImageChecker v10.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!